Literature DB >> 17438319

Linking cost sharing to value: an unrivaled yet unrealized public health opportunity.

R Scott Braithwaite1, Allison B Rosen.   

Abstract

As the financial burden of cost sharing continues to rise, patients increasingly avoid necessary care, thereby contributing to the high morbidity and mortality of the U.S. population compared with that of other developed countries. The rationale for cost sharing is often based on the moral hazard argument, which states that individuals may overuse care if they do not share in its costs. We evaluate this argument in detail, using it to distinguish between appropriate and inappropriate settings for cost sharing. Cost sharing may be appropriate when health services are of low value (low ratio of benefits to costs), whereas it is inappropriate when health services are of high value (high ratio of benefits to costs). In practice, cost sharing is rarely linked to value, and therefore much of the cost sharing that currently occurs is inappropriate and harmful. Cost-effectiveness analysis is an objective method to estimate the value of health services and may be a way to systematically evaluate whether cost-sharing policies are appropriate. Systematic efforts to discourage inappropriate cost sharing may improve public health.

Entities:  

Mesh:

Year:  2007        PMID: 17438319     DOI: 10.7326/0003-4819-146-8-200704170-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.

Authors:  Michele Heisler; Hwajung Choi; Allison B Rosen; Sandeep Vijan; Mohammed Kabeto; Kenneth M Langa; John D Piette
Journal:  Med Care       Date:  2010-02       Impact factor: 2.983

2.  The impact of the Medicare Part D prescription benefit on generic drug use.

Authors:  James X Zhang; Wesley Yin; Shawn X Sun; G Caleb Alexander
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

3.  Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.

Authors:  Marya Viorst Gwadz; Linda M Collins; Charles M Cleland; Noelle R Leonard; Leo Wilton; Monica Gandhi; R Scott Braithwaite; David C Perlman; Alexandra Kutnick; Amanda S Ritchie
Journal:  BMC Public Health       Date:  2017-05-04       Impact factor: 3.295

4.  Are German patients burdened by the practice charge for physician visits ('Praxisgebuehr')? A cross sectional analysis of socio-economic and health related factors.

Authors:  Ina-Maria Rückert; Jan Böcken; Andreas Mielck
Journal:  BMC Health Serv Res       Date:  2008-11-12       Impact factor: 2.655

5.  Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model.

Authors:  R Scott Braithwaite; Cynthia Omokaro; Amy C Justice; Kimberly Nucifora; Mark S Roberts
Journal:  PLoS Med       Date:  2010-02-16       Impact factor: 11.069

6.  A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial.

Authors:  Alicen Spaulding; A Mark Fendrick; William H Herman; James G Stevenson; Dean G Smith; Michael E Chernew; Dawn M Parsons; Keith Bruhnsen; Allison B Rosen
Journal:  Implement Sci       Date:  2009-04-07       Impact factor: 7.327

7.  The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial.

Authors:  Jennifer M Griffith; Carmen L Lewis; Alison R T Brenner; Michael P Pignone
Journal:  BMC Med Inform Decis Mak       Date:  2008-01-24       Impact factor: 2.796

8.  Can European Countries Improve Sustainability of Health Care Financing through Patient Cost-Sharing?

Authors:  Marzena Tambor; Milena Pavlova; Stanisława Golinowska; Wim Groot
Journal:  Front Public Health       Date:  2015-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.